VEDBAEK, Denmark, May 23, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ) today announced that results from a diagnostic program on the potential of using circulating microRNAs in serum as companion diagnostic biomarkers has been selected for presentation at the 2011 ASCO meeting to be held June 3-6 in Chicago.
